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We describe a cell damage-induced phenotype in mammary carcinoma cells
involving acquisition of enhanced migratory and metastatic properties.
Induction of this state by radiation required increased activity of the Ptgs2
gene product cyclooxygenase 2 (Cox2), secretion of its bioactive lipid
product prostaglandin E2 (PGE2), and the activity of the PGE2 receptor
EP4. Although largely transient, decaying to low levels in a few days to a
week, this phenotype was cumulative with damage and levels of cell
markers Sca-1 and ALDH1 increased with treatment dose. The Sca-1+,
metastatic phenotype was inhibited by both Cox2 inhibitors and PGE2
receptor antagonists, suggesting novel approaches to radiosensitization.
1. Introduction
Cancer cells that survive cytotoxic therapies such as
radiation or genotoxic agents can become highly resis-
tant to further treatment and develop an increased
capacity for repopulation, invasion, and metastasis
(Lee et al., 2017; Weng et al., 2013; Woodward et al.,
2007). The underlying mechanisms that lead to such
treatment-induced tumorigenic properties are of clini-
cal importance but not yet fully understood. Our stud-
ies showed that such cells expressed high levels of the
surface marker Sca-1 (stem cell antigen-1, also known
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as Ly6A). Sca-1 is a mouse glycosylphosphatidylinosi-
tol-anchored surface protein (GPI-AP), initially used
as a marker of hematopoietic stem cells (SC) (Bradfute
et al., 2005; Holmes and Stanford, 2007) and more
recently some populations of mammary tumor initiat-
ing cells (TIC) (Weng et al., 2012). Sca-1 is regulated
downstream of Wnt/beta-catenin signaling and is
thought to play a functional role in mammary cancer
tumor initiation and cells undergoing a cellular wound
healing response, triggered by cell death and migration
(Batts et al., 2011). Mammary tumor cell populations
responding to cytotoxic therapy (Lee et al., 2017;
Weng et al., 2013; Woodward et al., 2007) may
undergo dedifferentiation to a more resistant state in a
fraction of the population. A similar phenomenon was
termed the ‘Phoenix Rising’ response and was shown
to be triggered through activation of caspases 3 and 7
induction of phospholipase A2 (Huang et al., 2011; Li
et al., 2010).
In this study, we have examined the properties of
cells expressing high levels of Sca-1 after cytotoxic
treatment and key mechanisms involved in increased
tumor cell migration and metastasis. In previous stud-
ies, increased resistance to radiation and enhanced
metastasis was found in a population of primary
mouse mammary cells expressing cell surface Sca-1
(Holmes and Stanford, 2007; Weng et al., 2012,
2013). In this study, we showed that radiation induces
cells (4T1, MMT) expressing high levels of Sca-1
which exhibit enhanced migratory and metastatic
activities. The response required induction of cyclooxy-
genase 2 (Cox2) and its bioactive lipid product prosta-
glandin E2 (PGE2). This phenotype was however
inhibited by both Cox2 inhibitors and PGE2 receptor
antagonists, leading to profound inhibition of radia-
tion-induced metastasis.
2. Results
2.1. Enrichment in subpopulations of mammary
carcinoma cells expressing elevated surface
levels of Sca-1 after cytotoxic treatment
Surface levels of Sca-1 were shown previously to be
increased in radioresistant, invasive, and metastatic
MMT mammary carcinoma cells in vitro and in vivo
(Weng et al., 2013). In this study, we used 4T1 murine
mammary rather than MMT for most studies as
MMT, being primary cells grew for only one to two
generations in vitro. When 4T1 carcinoma cells were
treated with gamma-irradiation in fractions of 6 Gy
for up to three times, the population of cells positive
for Sca-1 was found to increase with escalating dose
(Fig. 1A, B) and similar changes were observed using
immunocytochemical (ICC) staining (Fig. 1C–F). Irre-
spective of whether cells were irradiated daily or every
second day, similar increases in the numbers of Sca-1-
positive cells were observed (Fig. 1C–F). Although the
degree to which Sca-1 increases differed in cells irradi-
ated one, two or three times, the kinetics of expression
and decay were similar, with significant increases
observed on day 6, induction peaking on day 9 and
Sca-1 levels thereafter declining (Fig. 1G). On day 21,
the Sca-1 levels had almost returned to the baseline in
each case, although a small number of Sca-1+ cells
were retained (Fig. 1G). Interestingly, re-exposure of
previously irradiated cells after decay in Sca-1 levels,
regardless of whether once or three times pretreated,
boosted the expression of Sca-1 (Fig. 1H). Cells thus
seemed to have a prolonged molecular memory of pre-
vious irradiations in terms of re-induction of Sca-1. In
addition to radiation treatment, Sca-1+ cells were also
induced by the cytotoxic drugs doxorubicin and
Fig. 1. Genotoxic stress leads to enrichment of Sca-1 in the 4T1 cell line and in MMT mammary tumors. (A) 4T1 cells were irradiated with
6 Gy for up to three times. After IR, cell culture medium was replaced and cells were collected for FACS analysis with the indicated
antibodies. (B) The mean percentage of CD44 and Sca-1 double-positive cells in three repeated experiments is shown  SD. (C–F) 4T1 cells
were irradiated every second day (C) or every day (E) and Sca-1 expression assessed by ICC staining, scale bar 20 lm. The mean
percentage of Sca-1-positive (red-stained) cells is also shown  SD (D and F). (G) Timeline of Sca-1 induction in 4T1 cells irradiated with
6 Gy for one, two, or three times. The cells were collected at the indicated times, stained with Sca-1 mAb, and analyzed by FACS. (H) Cells
treated as in G were irradiated again with 6 Gy twice on day 30 and 32 when Sca-1 levels had returned to baseline, and then assayed for
the re-expression of Sca-1 after overnight culture. The P values were obtained by re-irradiated cell to non-re-irradiated cells previously
irradiated one, two, or three times. (I) MMT tumor cells were transplanted into wild-type C57BL/6 mammary fat pad as described in
Experimental procedures. On day 10, established tumors were treated with 9 Gy radiotherapy. Sca-1 expression with tumor sections was
assessed by IHC on days 3 and 5 after treatment, scale bar 20 lm. (J) Mean numbers of Sca-1+ cells in imaged IHC MMT tumor sections
is shown  SD. (K) 4T1 cells were stained with anti-CD44 and anti-Sca-1 mAbs, and then, Sca-1 population was selected by cell sorting
(left side). Sca-1 4T1 tumor cells were then separated into a nonirradiated sample and an irradiated 6 Gy 9 2 every other day sample.
After ON culture, the cells were stained with anti-Sca-1 and-CD44 mAbs and analyzed by FACS and ICC, scale bar 20 lm. (L) The Sca-1
population of 4T1 cells were irradiated with 6 Gy once, twice or three times, and then analyzed by FACS. Nonirradiated cells were used as
controls. The percentage of Sca-1+ cells is presented in the bar graph.
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cisplatin, indicating a general response to genotoxic
stress (Fig. S1).
When we examined the effects of tumor irradiation
in vivo, we observed a similar phenomenon, with cells
staining positive for Sca-1 (Fig. 1I). Significant
increases in Sca-1+ cells were observed within tumor
sections on day 3, increasing to day 5 (Fig. 1I, J).
We next tested the possibility that enrichment of
Sca-1+ cells was due to preferential killing of radia-
tion-sensitive Sca-1 cells. To determine the origin of
Sca-1+ cells, 4T1 mammary carcinoma cells were
sorted to select the Sca-1 cells (Fig. 1K), and the
Sca-1 cells were then exposed to radiation. Even
though these populations were selected to exclude Sca-
1+ cells, radiation still led to the expression of Sca-1,
with up to 33% of these cells becoming Sca-1+ after
three 6 Gy radiation exposures (Fig. 1K, L). To exam-
ine whether the observed enrichment of Sca-1+ cells
was due to divergent rates of radiation-induced cell
death between Sca-1+ and Sca-1 cells, we examined
cell viability within each of these populations after
treatment. Unlike lymphoid-derived cancer cells that
readily undergo apoptosis after irradiation the fate of
most irradiated tumor cells of epithelial origin is senes-
cence, necrosis, or a slow form of death termed mitotic
catastrophe. These latter fates of epithelial tumor cells
are alternative outcomes to apoptosis, which is largely
inaccessible to many types of cancer due to frequent
genetic disruptions in the apoptotic pathway. Thus, in
most tumor types of epithelial origin, apoptosis is rare.
At the dosages used in this study, our analysis showed
no statistical difference in cell viability between irradi-
ated and nonirradiated cells within 24 h after irradia-
tion (Fig. S2A). In addition, no statistical difference in
cell viability was observed between Sca-1+ and Sca-1
cells within irradiated samples (Fig. S2B). Together,
these data indicate irradiation strongly induces Sca-1
expression by a mechanism that does not involve selec-
tive cell death of Sca-1 cells.
2.2. Irradiation induces Sca-1-expressing cells
with enhanced migratory and metastatic ability
Our previous experiments had shown the Sca-1+
MMT mammary tumor cells to have enhanced migra-
tory and metastatic properties (Weng et al., 2012).
This was true both for the fraction of such cells pre-
sent in untreated MMT mouse mammary cell popula-
tions in vivo that mediate cell renewal and the
radiation-induced Sca-1+ fraction (Weng et al., 2013;
Weng et al., 2012). To further determine the properties
of the Sca-1+ cells in 4T1 cells, they were exposed to
ionizing radiation then assayed for migratory ability,
using a double-chamber method. Irradiation markedly
increased the cell number capable of penetrating the
filter (Fig. 2A, B). To determine the phenotype of the
cells passing through the filter, Sca-1+ and Sca-1 4T1
cells were selected by cell sorting, and then twice irra-
diated with 6 Gy and subjected to cell migration assay.
Consistent with the findings in Fig. 2A, B, no cells in
the Sca-1 population passed through the filter if non-
irradiated. In contrast, many cells in both irradiated
Sca-1 and Sca-1+ populations migrated through the
filter (Fig. 2C, D). Moreover, cells that migrated
through the filter were Sca-1+ whether from either
sorted Sca-1 or Sca-1+ populations (Fig. 2C, D).
The absolute numbers of cells passing through the fil-
ter in the irradiated Sca-1+ cells were more than those
in the irradiated Sca-1 cells (Fig. 2C, D). These
results indicate Sca-1+ cells, regardless of their origin
from Sca-1+ or Sca-1 cell populations, possess
enhanced migratory ability. We next examined the
effects of radiation on MMT tumor metastasis in vivo.
We chose this mouse mammary tumor model as MMT
cells have been engineered to express GFP and can
thus be positively identified and distinguished from
normal cells in metastatic tissues. ICC staining of sec-
tions of primary MMT tumors growing in the mam-
mary fat pads had shown marked enrichment for Sca-
1 after radiation treatment (Fig. 1I). Analysis of the
draining lymph nodes from the same animals indicated
marked increases in Sca-1-stained cells (Fig. 2E, F).
These findings therefore suggested increased metastasis
of the Sca-1+ cells after radiotherapy. Metastasis from
the primary site was confirmed by detection of GFP-
expressing tumor cells in the lymph nodes after irradi-
ation of the primary site that also stained positive for
Sca-1 (Fig. 2G).
2.3. Changes in gene expression after
radiotherapy
To further define the phenotypes of Sca-1+ cells pro-
duced in response to radiation treatment, we next
examined the relative expression of a subset of
mRNAs in irradiated tumor cells using a qPCR array
specific for TIC-associated genes (Fig. S3A). The
mRNA species that were up- or downregulated in 4T1
cells in response to radiation are therefore shown in
Fig. S3A. Genes upregulated in irradiated 4T1 cells
included Aldh1a1 (Nozaki et al., 2017) and inducible
nitric oxide synthase Nos2 (Kim et al., 2013) known to
be increased in TIC, Pecam-1, Lin28A, and Ptprc/
CD45 which participate in cancer and embryonic stem-
ness (Lin et al., 2014; Shyh-Chang and Daley, 2013;
Williamson et al., 2013), luminal progenitor marker
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Fig. 2. Irradiation induces Sca-1-expressing cells with enhanced migratory and metastatic ability. (A) 4T1 cells were irradiated with 6 Gy 92
and assayed for cell migration using a two-chamber method. Irradiated or control 4T1 cells were placed in triplets on the filter of upper side
of a migration chamber and cultured. At the indicated times, the filters were gently removed and the cells on the upper side of filter were
cleared. The cells in the lower side of filter were fixed with 4% paraformaldehyde and stained with 0.5% crystal violet. Filters were then
photographed with representative fields shown, scale bar 50 lm. (B) Mean number of migrated cells per field under 109 magnification is
shown  SD. The P values were obtained by comparing the mean number of migrated cells between nonirradiated cells (0 Gy) and
irradiated cells. (C and D) 4T1 cells were sorted into Sca-1 () or Sca-1 (+) cells that were then treated with twice 6 Gy every other day.
The migration ability of these cells was measured by a two-chamber method. After 6 h of culture, the cells migrated to the other side of
the filter were stained with 0.5% Crystal violet or anti-Sca-1 antibody, scale bar 50 lm. The cells were counted and mean cells per field is
presented in the bar graph for each condition  SD. (E) Sca-1 expression was assessed by IHC staining of draining lymph node sections of
nonirradiated MMT tumors and tumors 3 and 5 days after 9 Gy irradiation, scale bar 20 lm. (F) The percentage of Sca-1-positive cells in
draining lymph nodes is represented  SD. (G) GFP-MMT tumor cells within the draining lymph nodes of wild-type C57BL/6 mice could be
detected by GFP expression and were positive for Sca-1.
5Molecular Oncology (2018) ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
J. Gong et al. Radiation induces metastatic phenotype via PGE2
c-Kit (Visvader and Stingl, 2014), and ABCG2, a pro-
tein involved in SC chemoresistence (An and Ongkeko,
2009). Real-time RT-qPCR confirmed large increases
in Sca-1 and Aldh1a1 mRNA (Fig. S3B). Of note, Ald-
h1a1 was upregulated 10- to 12-fold compared with
levels in control cells (Fig. S3). These data were also
confirmed by the finding that ALDH enzymatic activ-
ity was significantly increased in the irradiated murine
4T1 (Fig. S4A, B) and human MCF7 mammary carci-
noma cells (Fig. S4C, D). In addition, the ALDH-
enriched 4T1 population also had a Sca-1+ phenotype
as determined using a triple staining/flow cytometry
approach (Fig. S4E). Exposure to radiation thus led to
a profound increase in the subpopulation of cells with
elevated levels of surface Sca-1 and intracellular
ALDH1.
2.4. The Sca-1+/ALDH1+/migratory phenotype
was induced using medium conditioned by
irradiated cancer cells
As secreted products can mediate radiation resistance,
we next asked whether induction of the Sca-
1+CD44+ALDH1+ migratory phenotype could simi-
larly be caused by factor(s) released from irradiated
cells (Brocard et al., 2015; Dent et al., 2003). Tissue
culture medium conditioned by irradiated cells was
indeed able to cause formation of a large population
of Sca-1+ 4T1 cells when added to previously
untreated cultures (Fig. 3A, B). Unlike Sca-1+ cells in
irradiated cultures, most of which had an abnormal
cellular morphology and multiple and/or giant nuclei
(see Fig. 1C, E), cells treated with radiation-condi-
tioned medium maintained similar nuclear morphology
and size to controls (Fig. 3C). In addition, cells cul-
tured in radiation-conditioned medium acquired
enhanced migratory properties proportionate to the
dosage of radiation applied to cells from which the
medium was taken (Fig. 3E, F). Therefore, bioactive
substance(s) appear to be released from irradiated
cells mediating the induction of the Sca-1+/migratory
phenotype.
One secreted product that has been associated with
responses to tissue damage is PGE2 (Li et al., 2010).
Therefore, we considered the potential role of Cox2 a
key enzyme required for PGE2 synthesis in the pheno-
type. Radiation injury of 4T1 cells led to increased
Cox2 mRNA (Fig. 3G) and protein expression
(Fig. 3I). In addition, the levels of PGE2 detected in
the medium of irradiated 4T1 cells were increased in
a dose-dependent manner (Fig. 3H). Doxorubicin
treatment also induced amplification of Cox2 at the
protein level and PGE2 production (Fig. 3J, K). Thus,
PGE2 is released abundantly from irradiated or dox-
orubicin-treated cells and could be one mediator of the
cell damage-induced Sca-1+/migratory phenotype.
2.5. Suppression of radiotherapy-induced Sca-1+
by pretreatment with Cox2 inhibitors
To assess the role of Cox2 in the radiation-induced
Sca-1+ phenotype, we used the specific Cox2 inhibitor
celecoxib (McCormack, 2011). 4T1 tumor cells were
pretreated with celecoxib and irradiated with 6 Gy for
up to three times. Co-treatment with celecoxib was
effective in blocking induction of Sca-1+ by radiation
(Fig. 4A, B). Similar results were obtained in cells pre-
treated with ibuprofen, a nonsteroidal inhibitor of
both Cox1 and Cox2 (Davies, 1998) (Fig. 4A, B). Pre-
treatment with 50 lM of celecoxib or 100 lM ibuprofen
reduced the Sca-1+ cell numbers almost to back-
ground levels in radiation-treated cells (Fig. 4C, D).
Similarly, pretreatment with celecoxib or ibuprofen led
to a reduction in the cell population with ALDH
activity measured by ALDEFLUORTM assay (Fig. 4E,
F). The Sca-1+ fraction of irradiated cells was closely
associated with an enhanced migratory and metastatic
phenotype (Fig. 2) an effect that was almost com-
pletely inhibited by 50 lM celecoxib or 100 lM ibupro-
fen (Fig. 3G, H). These data provided further evidence
supporting the requirement for elevated levels of cellu-
lar Cox2 and extracellular PGE2 in the genotoxic
treatment-induced migratory, Sca-1+ cell phenotype.
As the cells appeared to be undergoing some level of
dedifferentiation after radiation, we also examined
tumorsphere formation, an index of tumor stem cell or
progenitor properties. Radiation increased tumor-
sphere formation and this effect was partly inhibited
by Cox2 inhibitors or antagonist of the PGE2 receptor
EP4 (Fig. 4I, J).
2.6. The PGE2 receptor EP4 supports the
genotoxic stress-induced Sca-1+ phenotype
We next asked whether the PGE2 receptor EP4 on the
4T1 cell surface was involved in the induction of Sca-
1+CD44+ (Fig. 5). Although cells can potentially
express at least four PGE2 receptor subtypes (EP1-4),
EP4 seems particularly significant in mammary cancer
metastasis (Kundu et al., 2009; Ma et al., 2006;
Reader et al., 2011). Blocking EP4 with its specific
antagonist L161,982 led to a drug dose-dependent
reduction in the formation of radiation-induced
Sca-1+ cells (Fig. 5A, B). The EP4 inhibitor also sup-
pressed the effects of radiation-conditioned medium on
upregulation of Sca-1+CD44+ in 4T1 cells (Fig. 5C,
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Fig. 3. Medium conditioned by cells exposed to genotoxic agents induces elevated Sca-1 levels and increased migration in nonirradiated
cells. 4T1 cells were cultured with medium derived from 4T1 cells irradiated with 6 Gy one, two, or three times. The radiation-conditioned
medium (med) was changed every other day. (A) 4T1 cells cultured with medium derived from irradiated cells were stained with the
indicated mAbs and analyzed by FACS. (C) Cells treated as in A were visualized with anti-Sca-1 antibodies, using ICC staining, scale bar
20 lm. The mean percentages of Sca-1-positive cells in three experiments are shown  SD (B, D). Cell migration assays were next carried
out on cells exposed to conditioned medium, using a two-chamber method (E, F). Cells treated as in A and C were placed in triplet wells on
the upper side of the filter and incubated for 12 h. The cells in the lower side of the chamber were then stained and counted, scale bar
50 lm (E). Representation of mean across three replicate experiments is shown  SD; P values were obtained by comparing cells cultured
with medium from nonirradiated cells with those obtained from one, two, or three times irradiated cells (F). (G) Ptgs2 mRNA expression
24 h post-IR measured by real-time qPCR normalized to Tbp. Expression is represented as ratio to nonirradiated sample. P value estimated
by one-way t-test of compiled fold change values to control. Figure shows representative mean of at least three independent experiments
 SD. (H) PGE2 levels in medium from irradiated or nonirradiated cells. Medium was collected at days 2–6 (D1–6) and quantified for PGE2
levels by ELISA. Compiled mean 6 Gy/0 Gy PGE2 ratios from at least three independent experiments are represented  SEM. (I) Cox2
protein expression analysis by western blot 24 h after a second 6 Gy irradiation. Densitometry-quantified Cox2 levels were normalized to
actin expression and shown as the mean of three independent experiments  SD. (J) Western blot analysis of Cox2 protein levels after
100 nM doxorubicin for 48 h. Densitometry-quantified Cox2 levels were normalized to actin expression and shown as the mean of three
independent experiments  SD. (K) 4T1 cells were treated with 100 nM doxorubicin for 48 h; growth media were then replaced, and PGE2
levels in the culture media were assayed by ELISA following 6 h of further culture. Mean fold difference in PGE2 levels is shown across
three replicate wells for each condition normalized to cell number within respective well  SD.
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Fig. 4. Suppression of IR-induced Sca-1 induction by Cox2 inhibitors. (A,B) 4T1 cells were preincubated with the indicated doses of
celecoxib or ibuprofen overnight and then irradiated with 6 Gy for up to three times every other day. Nonirradiated 4T1 cells treated with
the inhibitors acted as controls. On day 6, 4T1 cells were collected, stained with the indicated antibodies, and analyzed by FACS. Mean
percentages of CD44 and Sca-1 double-positive cells across three experiments are shown  SD (B). (C) ICC staining of cells pretreated with
50 lM celecoxib or 100 lM ibuprofen and then irradiated with 6 Gy for up to three times and stained with anti-Sca-1 antibodies, scale bar
50 lm. (D) The red Sca-1-positive cells (609) were counted, and the percentage of Sca-1-positive cells in three replicate experiments is
presented in the bar graph  SD. (E) ALDH activity was assessed by ALDEFLUORTM assay in 4T1 samples pretreated with 50 lM celecoxib
or 100 lM ibuprofen and irradiated with 6 Gy up to three times. On day 6, ALDH activity was assessed. DEAB-treated groups were used as
respective negative controls. The gated cells with green color indicate cells positive for ALDH activity. (F) The percentage of cells positive
for ALDH in three experiments is presented  SD. (G) Migratory potential of cells pretreated with 50 lM celecoxib or 100 lM ibuprofen and
irradiated with 6 Gy up to three times was assessed by the transwell migration assay. Representative images of counted fields are shown,
scale bar 50 lm. (H) Cells passing through the filter were counted at 409 magnification. Mean values representative of three experiments
are shown  SD. The P values were obtained by comparing irradiated cells without pretreatment of inhibitors with inhibitor-treated cells at
indicated doses. (I) 4T1 cells were assayed for tumorsphere formation in a 24-well ultra-low attachment plate after the indicated treatments.
Tumorspheres were imaged and quantified after seven days of culture as described in methods. Scale bar indicates 200 lm. (J) Mean
tumorsphere counts across quintuple wells for each condition is represented  SD, n = 2.
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Fig. 5. Inhibition of the cytoxan induction of Sca-1 by PGE2 receptor antagonists. (A) 4T1 cells were preincubated with the indicated doses
of L161,892 overnight and then irradiated with 6 Gy three times every other day. Nonirradiated 4T1 cells served as the controls. On day 6,
4T1 cells were collected, stained with indicated mAbs, and analyzed by FACS. (B) Mean percentages of CD44 and Sca-1 double-positive
cells across three experiments are shown  SD. The P values were obtained by comparing irradiated cells treated without or with inhibitor
at indicated doses. (C) 4T1 cells were cultured for 5 days with medium derived from the groups in A. The medium was changed every
second day. 4T1 cells were stained with the indicated mAbs and analyzed by FACS. (D) Mean percentages of CD44 and Sca-1 double-
positive cells across three experiments are shown  SD. The P values were obtained by comparing cells cultured in conditioned medium to
cells cotreated with conditioned medium and L161,982 at the indicated doses. (E) 4T1 Sca-1 surface expression was measured by flow
cytometry for cells treated with 100 nM doxorubicin and with or without 40 lM celecoxib or 20 lM L161,982 for 48 h. (F) Mean percentage
of Sca-1-positive cells after indicated treatments  SD. Representative experiment shown, n = 5. (G) Sca-1 expression within MMT tumors
and draining lymph nodes was assessed in vivo by IHC after irradiation (IR) of tumor cells pretreated with or without indicated
concentrations of celecoxib or L161,982, scale bar 20 lm. (H) Quantification of Sca-1+ cells within irradiated and nonirradiated MMT tumors
(above) and draining lymph nodes (below) is shown, representative of triplicate assays  SD.
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D). Celecoxib and L161,982 also prevented the
increases in the Sca-1+ population induced by doxoru-
bicin treatment (Fig. 4E, F). The cumulative results
from these studies (Figs 1–5) therefore suggested a cell
damage-induced programming pathway for this Sca-
1+/metastatic phenotype with steps including: Tumor
cell injury > Cox2 > PGE2 > PGE2-R > metastatic
Sca-1+ cells.
2.7. Effectiveness of Cox2 inhibitors and EP4
antagonists in reducing radiation-induced tumor
metastasis
We next examined the role of Cox2 and PGE2 in the
induction of Sca-1 expression and tumor metastasis
in vivo in the MMT mouse tumor model (Fig. 5G, H).
MMT cells were pretreated with celecoxib (50 lM) or
L161,982 (10 lM) overnight, and then, 106 of such cells
were inoculated into cleared mammary fat pads. As
before, radiation led to increases in Sca-1+ cells in
tumors and lymph node metastases (Fig. 5G, H, left
panels). However, these effects of tumor irradiation
were potently inhibited by the Cox2 inhibitor celecoxib
and the EP4 antagonist L161,982 (Fig. 5G, H, middle
and right panels).
3. Discussion
Our data therefore pointed to a mechanism of dose-
dependent, cytotoxic treatment-induced induction of
mammary carcinoma cells with enhanced migratory,
metastatic, and treatment resistant properties (Figs 1
and 2, Fig. S1). Cells and tumors treated with cyto-
toxic therapies exhibited a large increase in surface
Sca-1+, enhanced migration in vitro, and increased
metastasis. Increases in Sca-1 levels and migratory
potential also correlated with ALDH activity in 4T1
cells, and equivalent radiation treatments also induced
ALDH activity in human MCF7 breast cancer cells
(Fig. S4). The cluster of properties observed in the
Sca-1+ALDH1+ cells are sometimes observed in can-
cer stem cells (CSC) (Marcato et al., 2011), and popu-
lations sorted for this CSC phenotype typically possess
highly invasive and metastatic properties (Weng et al.,
2012). However, although irradiated cells showed some
increases in properties ascribed to CSC (Sca-1 induc-
tion, ALDH expression, tumorsphere formation), it is
not clear to what degree the cells correspond to known
populations of normal mammary SC. It may be that
cell populations exposed to the cytotoxic treatments
respond in a homeostatic manner by acquiring some
stem-like properties through dedifferentiation of pro-
genitor or differentiated mammary tumor cells. The
two genes observed to be most upregulated in irradi-
ated 4T1 cells were ALDH1 and Sca-1 itself (Fig. S3).
In addition to being stem cell markers, ALDH family
proteins play functional roles, protecting stem cells
from cytotoxic agents (Ma and Allan, 2011; Tomita
et al., 2016). Sca-1 is a surface GPI-AP, localizing to
lipid rafts in cancer cells, and may play a key role in
regulating cell migration through signaling mechanisms
including modulation of Src family kinase activity
(Batts et al., 2011; Holmes and Stanford, 2007). It has
also been suggested that a Sca-1 ligand may exist
(Holmes and Stanford, 2007), and it would be tempt-
ing to speculate that such a ligand could contribute to
the effects of radiation-conditioned medium on cell
migration. Irradiated cells also underwent a large
increase in c-kit mRNA (Fig. S3), an important factor
in hematopoietic stem cell expansion (O’Laughlin-Bun-
ner et al., 2001). Thus, further expression profiling of
the Sca-1-rich fraction of irradiated cells would be
desirable to expand our understanding of mechanism.
The finding that exposure to conditioned medium
from irradiated cells could induce Sca-1 surface expres-
sion and increase cell migration in cells indicates that
products secreted into the medium were mainly
responsible for inducing this phenotype. Consistent
with past reports, we found increased Cox2 activity
and PGE2 production to be important factors for the
Sca-1+ phenotype, further underlining the importance
of PGE2 in cell damage-induced regenerative responses
(Allen et al., 2015; Huang et al., 2011). PGE2 is
thought to be involved in triggering the Wnt-beta-cate-
nin pathway known to be activated by irradiation and
leading to radiation-induced stemness (Goessling et al.,
2009; Woodward et al., 2007). In addition, Cox2
expression and PGE2 release have been shown to be
dependent on activation of the transcription factor
NFkB (Nakao et al., 2002), which itself is induced by
ionizing radiation (Dent et al., 2003; Huang et al.,
2011; Wang et al., 1996). The findings that radiation-
induced mammary tumor metastasis could be reduced
both by Cox2 inhibitors and EP4 antagonists in tumor
bearing mice may be highly significant (Fig. 5G, H).
Inclusion of such agents in fractionated radiotherapy
protocols could thus be desirable.
In summary therefore, our studies have indicated
the inherent plasticity of mammary cancer cells and
their ability to respond to genotoxic stress through the
transient induction of cells with enhanced migratory
and metastatic properties. These findings have discern-
able implications for fractionated radiotherapy if such
resistant and metastatic cells were to accumulate pro-
gressively in the cancers of human patients with each
dose. However, the changes we observed here
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appeared in other studies to be triggered in tandem
with radiation-induced activation of tumor immuno-
genicity and specific cell killing by cytotoxic T cells
(Formenti and Demaria, 2012; Surace et al., 2015).
Competition between the pro-metastatic and immuno-
genic effects of radiation may therefore mold overall
responses to treatment. Our demonstration that radia-
tion-induced migration and metastasis could be
induced by secreted factors suggests that these may
encompass a series of accessible therapeutic targets, of
which targeting secreted eicosanoid products have been
exemplified herein.
4. Experimental procedures
4.1. Cell maintenance, irradiation, and inhibitors
4T1 and MCF7 cells were purchased from The Ameri-
can Type Culture Collection and cultured in Dulbecco’s
modified of Eagle’s medium (DMEM) with 10% heat-
inactivated fetal calf serum, 2 mM L-glutamine, and
100 lgmL1 of both penicillin and streptomycin (Cell-
gro, Mediatech, Tewksbury, MA, USA) in a Heracell
CO2 incubator at 37 °C and 5% CO2. For irradiation
treatment, cells were plated in 100-mm tissue culture
plates overnight and irradiated at the required doses
with a Cesium137 source at a dose rate of
1.06 Gymin1 or 2.29 Gymin1. Cisplatin was pur-
chased from Cayman Chemical Company (Ann Arbor,
MI, USA) (L161,982), and ibuprofen, doxorubicin,
and celecoxib were from Sigma, Franklin, MA, USA.
MMT mammary tumor cells were from mice doubly
transgenic for human mucin 1 Ag and polyomavirus
middle T (PyMT) oncogene (Xia et al., 2003). MMT
mice were a kind gift from Sandra J. Gendler, Mayo
Clinic, Scottsdale, AZ. Such MMT mice carrying the
PyMT oncogene driven by the mouse mammary tumor
virus long terminal repeat developed mammary carci-
noma at a 100% incidence (Guy et al., 1992).
4.2. FACS and immunocytochemical (ICC)
staining
Cells were lifted with Accutase (ThermoFisher
Scientific, Franklin, MA, USA) and washed in phos-
phate-buffered saline pH7.4 and then stained with
Fixable Viability Dye eFluor 450 and antibody
against Sca-1 (eBioscience, Franklin, MA, USA). For
indicated experiments, cells were further stained
with anti-CD44 mAb (eBioscience) using standard
immunofluorescence staining method. The Sca-1 sin-
gle- or Sca-1+CD44+ double-positive cells were quan-
tified by FACS (Gallios, Beckman Coulter, Pasadena,
CA, USA) and analyzed with FlowJo or FACScan.
Dead cells were omitted from marker quantification
based upon viability dye staining. To examine Sca-1
expression by ICC, cells (1 9 104 per plate) were cul-
tured in small culture plates for indicated days after
radiation treatment, cytocentrifuged onto the slide,
and then stained with anti-Sca-1 antibody by standard
ICC staining method and examined under light micro-
scope. For Fig. S1A, cells were cultured on coverslips,
fixed with 4% paraformaldehyde and permeabilized
with 0.1% Triton-9100. Cells were then stained with
Sca-1 antibody and mounted using ProLong Gold
Antifade Mountant with DAPI (ThermoFisher
Scientific).
4.3. Cell migration assays
Multiwell cell migration assays were performed follow-
ing established protocol (Kouspou and Price, 2011).
Multiwell chambers were incubated for the indicated
time upon which cells on the upper side of filter were
removed and those underside were then fixed and
stained with 0.5% crystal violet staining or Sca-1 anti-
bodies. Cells were counted using 409 magnification.
4.4. Western blotting
Cell lysates were collected in RIPA buffer (Boston
BioProducts, Ashland, MA, USA) containing HaltTM
Protease and Phosphatase Inhibitor Cocktail (Thermo
Scientific, Orlando, FL, USA). Protein content of sam-
ples was derived using PierceTM BCA Protein Assay
Kit (Thermo Scientific). Equal protein from cell lysates
wase subjected to SDS/PAGE followed by established
western blot procedure (Chou et al., 2015). Primary
and secondary antibodies listed in Supporting informa-
tion. The Ag/Ab signals were quantified with ECL
reagent (GE) and autoradiography film (HyBlot CL,
Denville Scientific, Holliston, MA, USA) or LI-COR
Odyssey (Lincoln, MA, USA). Immobilon-FL and
Immobilon-P poly(vinylidene difluoride) membranes
(Merck Millipore, Burlington, MA, USA) were used
for near-infrared (Odyssey) and HRP (HyBlot CL)
detection methods, respectively. Densitometry of the
membranes was performed using Image Studio Lite
(LI-COR Biosciences). IMAGEJ was used to adjust con-
trast of western blot figure images without disturbing
the relative ratio of signal.
4.5. RT-qPCR
Total RNA was harvested 24 h following the indicated
treatment using RNeasy Mini Kit (Qiagen, Hilden,
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Germany) and converted to cDNA with iScript cDNA
Synthesis Kit (Bio-Rad, Hercules, CA, USA). Quanti-
tative PCR amplification of 10 ng cDNA was per-
formed using SYBR Green PCR Master Mix and 7300
Real Time PCR System (Thermo Fisher Scientific,
Asheville, NC, USA) with cycle conditions: 50 °C
2 min, 95 °C 10 min, [95 °C 15 s, 60 °C 1 min] 9 40
cycles. Dissociation curve analysis confirmed single
PCR products. Amplicon amplification efficiency and
Ct values were determined using the LINREGPCR soft-
ware (Ruijter et al., 2009). Amplicon primer sequences
are provided in the Supporting information with corre-
sponding PrimerBank ID where appropriate (Wang,
2003).
4.6. PGE2 quantification by ELISA
Samples of radiation-treated cell-conditioned media
and control media were collected and frozen at
80 °C until analysis. Media samples from doxoru-
bicin-treated cells were collected by replacing media on
cells treated with doxorubicin for 48 h with agent-free
growth media and culturing cells for a further 6 h at
which time the media were collected and stored at
80 °C. Cells were lifted and counted for normaliza-
tion of PGE2 to sample cell number. Prior to ELISA
assay, the cultured media samples were thawed on ice
and clarified by centrifugation at 15 000 g for 150 at
4 °C. PGE2 levels were quantified using Prostaglandin
E2 ELISA Kit – Monoclonal (Cayman, Ann Arbor,
MI, USA) as per the manufacturer’s protocol.
4.7. Tumorsphere assay
Tumorsphere procedure was performed using methods
previously published (Chang et al., 2012; Grange
et al., 2008; Kim et al., 2010; Lee et al., 2015). 4T1
cells were treated as indicated, 24 h after second irradi-
ation, cells were lifted using trypsin or accutase and
strained through a 40-lm cell strainer (USA Scientific,
Orlando, FL, USA) and plated in 24-well ultra-low
attachment plates (Sigma-Aldrich, Natick, MA, USA)
at 8–10 cellslL1 in tumorsphere culture medium.
Tumorsphere culture medium consisted of DMEM/
F12 medium with HEPES buffer, 10 ngmL1 epider-
mal growth factor, 10 ngmL1 basic fibroblast growth
factor (Thermo Fisher Scientific), 4 lgmL1 heparin,
0.5% methylcellulose, 5 lgmL1 insulin (Sigma-
Aldrich, Natick, MA, USA), 0.4% bovine serum albu-
min (Thermo Fisher Scientific, Asheville, NC, USA),
and 1 lM hydrocortisone (Stem Cell Technologies,
Vancouver, BC, Canada). Tumorspheres were incu-
bated at 37 °C and 5% CO2 for 7 days at which time
they were imaged and counted using a Celigo High
Throughput Micro-Well Image Cytometer (Nexcelom
Bioscience, Lawrence, MA, USA). Tumorsphere
counts were performed using the Celigo tumorsphere
mask analysis setting with parameters selected such
that the minimum tumorsphere diameter was over
100 lm. General settings: analysis resolution, 4 lm per
pixel; well mask, 96%; well mask usage automatic.
Identification settings: colony diameter, 400 lm; preci-
sion, low; border dilation, 0; minimum thickness 0;
background correction, yes. Prefiltering settings: area,
1 9 104 to 2 9 106 lm; intensity range, 0 to 255; min.
aspect ratio, 0.05.
4.8. Assessment of ALDH activity
Cells at 1 9 104 cellsmL1 were seeded in 100-mm
cell culture plates and irradiated with 6 Gy every sec-
ond day up to three irradiations. The ALDH activity
of the cells was assayed according by the ALDE-
FLUORTM assay according to the manufacturer’s
instructions (Stem Cell Technologies). Briefly, 106 cells
were resuspended in 1 mL of aldefluor assay buffer
with activated aldefluor substrate. As a negative con-
trol for each sample, an aliquot of ‘aldefluor-exposed’
cells were immediately quenched with a specific ALDH
inhibitor, DEAB. Following a 450 incubation at 4 °C,
the cells were centrifuged. Cell pellets were resus-
pended in 0.5 mL aldefluor assay buffer and analyzed
by FACS (Becton Dickinson, Franklin Lakes, NJ,
USA). For triple staining, suspended single cells were
stained with PE-conjugated Sca-1 and Cy-conjugated
CD44 mAbs, and then stained for ALDH+ cells as
described above. The ALDH+Sca-1+CD44+ cells
were analyzed by flow cytometry.
4.9. Radiotherapy in vivo
GFP+ MMT tumor cells (106) were inoculated into
the right and left mammary fat pads of wild-type
C57BL/6 mice. On day 10, the tumors (about 5 mm3)
in the right side received radiation at 9 Gy using
XRAD320 (Precision X-Ray Inc., Branford, CT,
USA). The mice were sacrificed on days 3 and 5 after
radiation. Then sections of tumor or draining lymph
node were prepared, stained with anti-Sca-1 antibod-
ies, and examined by light microscopy. Mice were
housed and handled in facilities accredited by the
American Association for the Accreditation of Labora-
tory Animal Care. The study was carried out in accor-
dance with the animal protocol approved by the
Institutional Animal Care and Use Committee of Bos-
ton University Medical Center. The mice were sedated
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with intraperitoneal administration of ketamine
(75 mgkg1) and xylazine (5 mgkg1), and then, the
tumor was irradiated with 9 Gy by XRAD 320 (Preci-
sion X-Ray Inc., N. Branford, CT, USA). The
XRAD320 is a self-contained X-ray system for deliver-
ing a precise radiation dosage to the tumor in small
animals. Thus, the systemic exposure of radiation was
avoided. The mice were closely followed and would be
euthanized if they showed inactivity, ruffled fur coat,
or anorexia.
4.10. Statistical analysis
Statistical significance was determined using Student’s
t-test or X2-test. One-way analysis of variance
(ANOVA) was used for analysis of data with more
than two subgroups and Tukey’s post hoc test was
used for further statistical inference between sub-
groups. P-values of < 0.05 were considered statistically
significant. SPSS STATISTICS software (IBM, Armonk,
NY, USA) and Microsoft Excel were used to attain
these values.
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